FIMANAC
LIVE

Serial Number

79307666

Owner

PCI Biotech AS

Attorney

Christian D. Abel

Filing Date

Mar 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

FIMANAC Trademark

Serial Number: 79307666 • Registration: 6868210

FIMANAC is a trademark filed by PCI Biotech AS on March 4, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

PCI Biotech AS (3 trademarks)

Ullernchausséen 64

Entity Type: 99

Trademark Details

Filing Date

March 4, 2021

Registration Date

October 11, 2022

Published for Opposition

April 26, 2022

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of cancer, for the treatment of a variety of skin conditions, for wound healing, for the treatment of eye diseases and conditions; pharmaceutical drugs being for treatment of cancer, treatment of skin conditions, treatment of wounds, treatment of eye diseases and conditions; cancer medicines, medicines for skin conditions, medicines for wound healing, medicines for eye diseases and conditions; vaccines; preventive vaccines; vaccine preparations; vaccine aids being vaccine preparations; vaccine adjuvants; pharmaceutical preparations for the treatment of cancer; pharmaceutical products being preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; nucleic acid sequences for medical and veterinary purposes; therapeutic drugs and agents for cancer treatment, for the treatment of a variety of skin conditions, for wound healing, for the treatment of eye diseases and conditions * ; none of the aforementioned products being ophthalmic pharmaceutical preparations for the treatment of inflammation *

Surgical apparatus and instruments; medical apparatus and instruments for treatment of cancer, for the treatment of a variety of skin conditions, for the treatment of wounds, for the treatment of eye diseases and conditions; veterinary apparatus and instruments for treatment of cancer, for the treatment of a variety of skin conditions, for the treatment of wounds, for the treatment of eye diseases and conditions; medical equipment for skin and tissue illumination; LED (light-emitting diode) lamps for medical use; LED (light-emitting diode) light sources for medical use; treatment lamps for medical purposes, namely light-induced therapy for cancer treatment, light-induced therapy for the treatment of a variety of skin conditions, for the treatment of wounds, for the treatment of eye diseases and conditions; lasers for medical use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 26, 2025 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 31, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 22, 2023 INPS
INVALIDATION PROCESSED
Sep 22, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 11, 2023 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2023 FINO
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Feb 14, 2023 NURC
FINAL DISPOSITION NOTICE SENT TO IB
Jan 30, 2023 FICS
FINAL DISPOSITION PROCESSED
Jan 30, 2023 FIMP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Jan 11, 2023 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Jan 11, 2023 COC.
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 11, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 11, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 11, 2022 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 26, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 7, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 7, 2022 OPNR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Sep 4, 2022 ETOP
LIMITATION OF GOODS RECEIVED FROM IB
Aug 27, 2022 LIMG
EXTENSION OF TIME TO OPPOSE RECEIVED
May 9, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 26, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 6, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2022 TROA
REFUSAL PROCESSED BY IB
Nov 5, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 14, 2021 RFCS
REFUSAL PROCESSED BY MPU
Oct 14, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 29, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 28, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 6, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 1, 2021 REPR